Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0148 Transporter Info
Gene Name SLC22A25
Transporter Name Organic anion transporter UST6
Gene ID
387601
UniProt ID
Q6T423
Epigenetic Regulations of This DT (EGR)

Methylation

  Hepatocellular carcinoma

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in hepatocellular carcinoma [ 1 ]

Location

 5'UTR (cg09488184)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.50E+00 Statistic Test p-value: 3.31E-14; Z-score: -2.92E+00

Methylation in Case

 4.00E-01 (Median) Methylation in Control 5.98E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in hepatocellular carcinoma [ 1 ]

Location

 Body (cg21292473)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.57E+00 Statistic Test p-value: 1.08E-17; Z-score: -5.56E+00

Methylation in Case

 4.55E-01 (Median) Methylation in Control 7.16E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC22A25 in hepatocellular carcinoma [ 1 ]

Location

 Body (cg11231434)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.24E+00 Statistic Test p-value: 2.92E-12; Z-score: -4.51E+00

Methylation in Case

 7.70E-01 (Median) Methylation in Control 9.51E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Bladder cancer

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in bladder cancer [ 2 ]

Location

 TSS1500 (cg18158015)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.10E+00 Statistic Test p-value: 5.06E-06; Z-score: -6.16E+00

Methylation in Case

 2.92E-01 (Median) Methylation in Control 6.13E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in bladder cancer [ 2 ]

Location

 Body (cg21961694)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.73E+00 Statistic Test p-value: 6.14E-09; Z-score: -1.01E+01

Methylation in Case

 4.53E-01 (Median) Methylation in Control 7.84E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in breast cancer [ 3 ]

Location

 TSS1500 (cg18158015)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 2.41E-02; Z-score: -1.76E-01

Methylation in Case

 8.47E-01 (Median) Methylation in Control 8.53E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in breast cancer [ 3 ]

Location

 1stExon (cg10319663)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 2.53E-02; Z-score: -4.62E-01

Methylation in Case

 7.34E-01 (Median) Methylation in Control 7.55E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC22A25 in breast cancer [ 3 ]

Location

 Body (cg21961694)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.13E+00 Statistic Test p-value: 7.31E-07; Z-score: -1.38E+00

Methylation in Case

 6.89E-01 (Median) Methylation in Control 7.80E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in pancretic ductal adenocarcinoma [ 4 ]

Location

 TSS1500 (cg10362591)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 2.25E+00 Statistic Test p-value: 2.25E-14; Z-score: 2.81E+00

Methylation in Case

 4.89E-01 (Median) Methylation in Control 2.17E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in pancretic ductal adenocarcinoma [ 4 ]

Location

 TSS1500 (cg05672265)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 8.44E-03; Z-score: -4.07E-01

Methylation in Case

 8.49E-02 (Median) Methylation in Control 9.26E-02 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC22A25 in pancretic ductal adenocarcinoma [ 4 ]

Location

 TSS1500 (cg11624728)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 4.06E-02; Z-score: -4.42E-01

Methylation in Case

 4.43E-01 (Median) Methylation in Control 4.76E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC22A25 in pancretic ductal adenocarcinoma [ 4 ]

Location

 Body (cg09681286)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 9.07E-03; Z-score: -8.42E-01

Methylation in Case

 8.04E-01 (Median) Methylation in Control 8.39E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in colorectal cancer [ 5 ]

Location

 TSS200 (cg21348565)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.03E+00 Statistic Test p-value: 7.74E-03; Z-score: -5.32E-01

Methylation in Case

 8.58E-01 (Median) Methylation in Control 8.83E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in colorectal cancer [ 5 ]

Location

 1stExon (cg10319663)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 1.32E-09; Z-score: -2.44E+00

Methylation in Case

 7.90E-01 (Median) Methylation in Control 8.58E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC22A25 in colorectal cancer [ 5 ]

Location

 1stExon (cg04409954)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 1.56E-04; Z-score: -1.24E+00

Methylation in Case

 9.36E-01 (Median) Methylation in Control 9.49E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC22A25 in colorectal cancer [ 5 ]

Location

 Body (cg21961694)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.41E+00 Statistic Test p-value: 4.36E-13; Z-score: -5.36E+00

Methylation in Case

 5.51E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in lung adenocarcinoma [ 6 ]

Location

 TSS200 (cg21348565)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 2.49E-02; Z-score: -1.17E+00

Methylation in Case

 8.15E-01 (Median) Methylation in Control 8.45E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in lung adenocarcinoma [ 6 ]

Location

 1stExon (cg10319663)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.07E+00 Statistic Test p-value: 4.83E-03; Z-score: -1.76E+00

Methylation in Case

 7.46E-01 (Median) Methylation in Control 8.00E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC22A25 in lung adenocarcinoma [ 6 ]

Location

 1stExon (cg04409954)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 1.38E-02; Z-score: -1.76E+00

Methylation in Case

 8.82E-01 (Median) Methylation in Control 9.15E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC22A25 in lung adenocarcinoma [ 6 ]

Location

 Body (cg21961694)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.22E+00 Statistic Test p-value: 6.40E-04; Z-score: -2.84E+00

Methylation in Case

 6.56E-01 (Median) Methylation in Control 7.98E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC22A25 in papillary thyroid cancer [ 7 ]

Location

 1stExon (cg04409954)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.00E+00 Statistic Test p-value: 2.63E-02; Z-score: -2.79E-01

Methylation in Case

 9.55E-01 (Median) Methylation in Control 9.58E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC22A25 in papillary thyroid cancer [ 7 ]

Location

 Body (cg21961694)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 1.79E-06; Z-score: -1.87E+00

Methylation in Case

 8.08E-01 (Median) Methylation in Control 8.74E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples
References
1 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
5 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
7 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.